Overview

Dapagliflozin Effects on Hypoglycemia

Status:
Active, not recruiting

Trial end date:
2021-11-30

Target enrollment:

Participant gender:

Summary

The purpose of this research study will be to test and evaluate if dapagliflozin has an effect on the amount of glucagon (a hormone produced by the pancreas and stomach that stimulates liver glucose production) produced by the body and if that change will improve recovery time from hypoglycemia (low blood sugar) in participants with Type 1 Diabetes.

Phase:

Phase 1

Details

Lead Sponsor:

University of California, San Diego

Collaborator:

Juvenile Diabetes Research Foundation

Treatments:

Dapagliflozin